BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10082449)

  • 1. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
    Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
    Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
    Bryowsky JJ; Bugnitz MC; Hak EB
    Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate.
    Profumo RJ; Reese JC; Foy TM; Garibaldi LR; Kane RE
    Transplantation; 1994 Jan; 57(2):301-3. PubMed ID: 8310527
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.
    Alos N; Eugène D; Fillion M; Powell J; Kokta V; Chabot G
    Horm Res; 2006; 65(6):289-94. PubMed ID: 16612105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of pamidronate in patients with renal failure and hypercalcemia.
    Machado CE; Flombaum CD
    Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia and childhood cancer: a 7-year experience.
    Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disodium pamidronate, bisphosphonate for malignant hypercalcaemia.
    Cantwell BM
    Ir Med J; 1990 Mar; 83(1):32-4. PubMed ID: 2193900
    [No Abstract]   [Full Text] [Related]  

  • 17. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
    Thiébaud D; Jacquet AF; Burckhardt P
    Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemia in primary oxalosis: role of increased bone resorption and effects of treatment with pamidronate.
    Yamaguchi K; Grant J; Noble-Jamieson G; Jamieson N; Barnes ND; Compston JE
    Bone; 1995 Jan; 16(1):61-7. PubMed ID: 7742085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
    Auron A; Tal L; Srivastava T; Alon US
    Pediatr Nephrol; 2009 Mar; 24(3):613-7. PubMed ID: 18839218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia.
    Tamion F; Bonmarchand F; Girault C; Chevron V; Leroy J
    Clin Nephrol; 1995 Feb; 43(2):138-9. PubMed ID: 7736680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.